Robert Kleemann

Навело

	Све	Од 2020
Наводи	17861	5511
h-индекс	67	40
i10-индекс	149	117

1200

600

300

900

19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202550 49 65 82 78 76 125 205 245 373 391 429 578 651 687 687 1003 972 899 864 929 877 904 909 939 1057 1174 1081 1062 190

Јавни приступ

Прикажи све

29 чланака

4 чланка

доступно

није доступно

На основу услова финансирања

Коаутори

T KooistraTNO Dept. Metabolic Health Research Leiden The NetherlandsВерификована је имејл адреса на tno.nl
Peter WielingaDirector PMO, Julius ClinicalВерификована је имејл адреса на juliusclinical.com
Martine MorrisonTNO, Metabolic Health Research, Leiden, The NetherlandsВерификована је имејл адреса на tno.nl
Juergen BernhagenProfessor and Chair of Vascular Biology, Ludwig-Maximilians-University (LMU) MunichВерификована је имејл адреса на med.uni-muenchen.de
Anita van den HoekTNO Dept. of Metabolic Health ResearchВерификована је имејл адреса на tno.nl
Hans MG PrincenThe Netherlands Organization of Applied Scientific Research (TNO), Metabolic Health ResearchВерификована је имејл адреса на tno.nl
Jan LindemanLeiden University Medical CenterВерификована је имејл адреса на lumc.nl
Ben van OmmenPrincipal Scientist, TNOВерификована је имејл адреса на tno.nl
Louis HavekesTNO Metabolic Health Research and Prof. Leiden University Medical Center, Leiden, the NetherlandsВерификована је имејл адреса на tno.nl
Jaap KeijerProfessor in Human and Animal Physiology, Wageningen UniversityВерификована је имејл адреса на wur.nl
Roeland HanemaaijerTNO Metabolic Health ResearchВерификована је имејл адреса на tno.nl
Reinout StoopMetabolic health research, TNOВерификована је имејл адреса на tno.nl
Peter HeeringaProfessor, University of GroningenВерификована је имејл адреса на umcg.nl
Bart StaelsProfesseur Université LilleВерификована је имејл адреса на pasteur-lille.fr
Thomas KelderCTO, EdgeLeap, The NetherlandsВерификована је имејл адреса на edgeleap.com
José van der HoornResearch Scientist/ project leader, TNO Metabolic Health Research, LeidenВерификована је имејл адреса на tno.nl
Chris EveloHead Department of Bioinformatics - BiGCaT, Maastricht University ORCID:0000-0002-5301-3142Верификована је имејл адреса на maastrichtuniversity.nl
Debby Koonen, PhDAssistant Professor, University Medical Center Groningen, The NetherlandsВерификована је имејл адреса на umcg.nl
Rory R KoenenProfessor Biochemistry of Vascular Inflammation and Thrombosis, CARIM, Maastricht UniversityВерификована је имејл адреса на maastrichtuniversity.nl
Pietro GhezziEx Univ Urbino. Emeritus Prof, Brighton & Sussex Med SchoolВерификована је имејл адреса на bsms.ac.uk

Прати

Robert Kleemann

TNO, Dept. Metabolic Health Research, Leiden, The Netherlands

Верификована је имејл адреса на tno.nl - Почетна страница

inflammation atherosclerosis NAFLD/NASH nutrition systems biology


Наслов Сортирај по наводима Сортирај по години Сортирај по наслову	Навело Навело	Година
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment J Bernhagen, R Krohn, H Lue, JL Gregory, A Zernecke, RR Koenen, ... Nature medicine 13 (5), 587-596, 2007	1504	2007
Cytokines and atherosclerosis: a comprehensive review of studies in mice R Kleemann, S Zadelaar, T Kooistra Cardiovascular research 79 (3), 360-376, 2008	975	2008
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 R Kleemann, A Hausser, G Geiger, R Mischke, A Burger-Kentischer, ... Nature 408 (6809), 211-216, 2000	766	2000
Mouse models for atherosclerosis and pharmaceutical modifiers S Zadelaar, R Kleemann, L Verschuren, J de Vries-Van der Weij, ... Arteriosclerosis, thrombosis, and vascular biology 27 (8), 1706-1721, 2007	714	2007
Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology W Liang, AL Menke, A Driessen, GH Koek, JH Lindeman, R Stoop, ... PloS one 9 (12), e115922, 2014	606	2014
Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease H Lue, R Kleemann, T Calandra, T Roger, J Bernhagen Microbes and infection 4 (4), 449-460, 2002	519	2002
Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models R Kleemann, L Verschuren, M Morrison, S Zadelaar, MJ van Erk, ... Atherosclerosis 218 (1), 44-52, 2011	480	2011
Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis A Burger-Kentischer, H Goebel, R Seiler, G Fraedrich, HE Schaefer, ... Circulation 105 (13), 1561-1566, 2002	404	2002
Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase R Kleemann, A Kapurniotu, RW Frank, A Gessner, R Mischke, O Flieger, ... Journal of molecular biology 280 (1), 85-102, 1998	394	1998
The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is … S Mandard, F Zandbergen, NS Tan, P Escher, D Patsouris, W Koenig, ... Journal of Biological Chemistry 279 (33), 34411-34420, 2004	356	2004
High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice RA van der Heijden, F Sheedfar, MC Morrison, PPH Hommelberg, D Kor, ... Aging (Albany NY) 7 (4), 256, 2015	327	2015
Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and … JHN Lindeman, H Abdul-Hussien, JH van Bockel, R Wolterbeek, ... Circulation 119 (16), 2209-2216, 2009	302	2009
Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis R Kleemann, L Verschuren, MJ Van Erk, Y Nikolsky, NHP Cnubben, ... Genome biology 8, 1-16, 2007	291	2007
Fibrates down-regulate IL-1–stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB–C/EBP-β complex formation R Kleemann, PP Gervois, L Verschuren, B Staels, HMG Princen, ... Blood, The Journal of the American Society of Hematology 101 (2), 545-551, 2003	282	2003
Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-α activator fenofibrate P Gervois, R Kleemann, A Pilon, F Percevault, W Koenig, B Staels, ... Journal of Biological Chemistry 279 (16), 16154-16160, 2004	274	2004
Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases H Abdul-Hussien, RGV Soekhoe, E Weber, JH von der Thüsen, ... The American journal of pathology 170 (3), 809-817, 2007	253	2007
Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro R Kleemann, L Verschuren, BJ de Rooij, J Lindeman, MM de Maat, ... Blood 103 (11), 4188-4194, 2004	250	2004
Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol–lowering effect in APOE* 3-Leiden transgenic mice: evidence for … R Kleemann, HMG Princen, JJ Emeis, JW Jukema, RD Fontijn, ... Circulation 108 (11), 1368-1374, 2003	236	2003
Role of macrophage migration inhibitory factor in obesity, insulin resistance, type 2 diabetes, and associated hepatic co-morbidities: a comprehensive review of human and … MC Morrison, R Kleemann Frontiers in immunology 6, 308, 2015	206	2015
MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease L Verschuren, T Kooistra, J Bernhagen, PJ Voshol, DM Ouwens, ... Circulation research 105 (1), 99-107, 2009	205	2009

Систем тренутно не може да изврши ову радњу. Пробајте поново касније.

Чланци 1–20

Годишњи број навода

Дупли наводи

Обједињени наводи

Додавање коаутораКоаутори

Прати

Навело

Коаутори